VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $192.29)
- $192.29 P/E (TTM): 23.02X Cap: $378M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $167.52)
- $167.52 P/E (TTM): 22.53X Cap: $7.60B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $23.72)
- $23.72 Cap: $9.26B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $192.29)
- $192.29 P/E (TTM): 23.02X Cap: $378M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $167.52)
- $167.52 P/E (TTM): 22.53X Cap: $7.60B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $50.23)
- $50.23 Cap: $4.78B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $192.29)
- $192.29 P/E (TTM): 23.02X Cap: $378M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $755.90)
- $755.90 P/E (TTM): 17.62X Cap: $79.44B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $203.90)
- $203.90 P/E (TTM): 19.6X Cap: $491.06B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,059.70)
- $1,059.70 P/E (TTM): 51.04X Cap: $1T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $97.76)
- $97.76 P/E (TTM): 12.55X Cap: $242.64B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $25.04)
- $25.04 P/E (TTM): 12.98X Cap: $142.37B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $587.48)
- $587.48 P/E (TTM): 33.09X Cap: $220.72B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $47.63)
- $47.63 P/E (TTM): 13.56X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $167.52)
- $167.52 P/E (TTM): 22.53X Cap: $7.60B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $23.72)
- $23.72 Cap: $9.26B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $192.29)
- $192.29 P/E (TTM): 23.02X Cap: $378M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $82.88)
- $82.88 P/E (TTM): 20.38X Cap: $687M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023